Growth Metrics

Alkermes (ALKS) EBIAT (2016 - 2026)

Alkermes has reported EBIAT over the past 16 years, most recently at $49.3 million for Q4 2025.

  • Quarterly EBIAT fell 66.14% to $49.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $241.7 million through Dec 2025, down 34.03% year-over-year, with the annual reading at $241.7 million for FY2025, 35.06% down from the prior year.
  • EBIAT was $49.3 million for Q4 2025 at Alkermes, down from $82.8 million in the prior quarter.
  • Over five years, EBIAT peaked at $237.1 million in Q2 2023 and troughed at -$64.0 million in Q3 2022.
  • The 5-year median for EBIAT is $42.3 million (2023), against an average of $46.5 million.
  • Year-over-year, EBIAT tumbled 21532.84% in 2021 and then soared 10995.19% in 2022.
  • A 5-year view of EBIAT shows it stood at $873000.0 in 2021, then soared by 10995.19% to $96.9 million in 2022, then surged by 65.76% to $160.6 million in 2023, then dropped by 9.23% to $145.7 million in 2024, then plummeted by 66.14% to $49.3 million in 2025.
  • Per Business Quant, the three most recent readings for ALKS's EBIAT are $49.3 million (Q4 2025), $82.8 million (Q3 2025), and $87.1 million (Q2 2025).